Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: J Alzheimers Dis. 2023;93(4):1563–1575. doi: 10.3233/JAD-230093

Fig. 1.

Fig. 1.

Spearman rank correlations between chronological age and second-generation DNAm markers at baseline. DNAm, DNA methylation. aDNAmPhenoAge is a validated novel epigenetic clock that predicts varying aging outcomes, including all-cause mortality, cancers, healthspan, physical functioning, and Alzheimer’s disease [4]. bDNAmGrimAge is a validated novel DNAm biomarker which predicts lifespan and all-cause mortality [5]. cDNAmTL is a DNA methylation measurement of telomere length (unit is per 100-base pairs) [6].